>
Switch to:

Tekla Life Sciences Investors Debt-to-Equity

: 0.00 (As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Tekla Life Sciences Investors's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2020 was $0.0 Mil. Tekla Life Sciences Investors's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2020 was $0.0 Mil. Tekla Life Sciences Investors's Total Stockholders Equity for the quarter that ended in Sep. 2020 was $483.6 Mil. Tekla Life Sciences Investors's debt to equity for the quarter that ended in Sep. 2020 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.


Tekla Life Sciences Investors Debt-to-Equity Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Debt-to-Equity 0.00 0.00 0.00 0.00

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Debt-to-Equity Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Tekla Life Sciences Investors Debt-to-Equity Distribution

* The bar in red indicates where Tekla Life Sciences Investors's Debt-to-Equity falls into.



Tekla Life Sciences Investors Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tekla Life Sciences Investors's Debt to Equity Ratio for the fiscal year that ended in Sep. 2020 is calculated as

Tekla Life Sciences Investors's Debt to Equity Ratio for the quarter that ended in Sep. 2020 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Tekla Life Sciences Investors  (NYSE:HQL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Tekla Life Sciences Investors Debt-to-Equity Related Terms


Tekla Life Sciences Investors Debt-to-Equity Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)